FSD Pharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA35954B4047
CAD
12.32
0.92 (8.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About FSD Pharma, Inc. stock-summary
stock-summary
FSD Pharma, Inc.
Pharmaceuticals & Biotechnology
FSD Pharma Inc is a Canada-based company engaged in the cultivation of cannabis. The Company through its wholly owned subsidiary, FV Pharma, operates as an authorized licensed producer of cannabis for medical purposes (ACMPR). In addition, the Company also owns stakes in Canara, which specializes in indoor cultivation.
Company Coordinates stock-summary
Company Details
FIRST CANADIAN PLACE, 100 KING STREET WEST, SUITE 3400 TORONTO ON : M5X 1A4
stock-summary
Tel: 1 416 8548884
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 31 Foreign Institutions (4.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Raza Bokhari
Executive Co-Chairman of the Board, Chief Executive Officer
Mr. Anthony Durkacz
Executive Co-Chairman of the Board
Mr. Zeeshan Saeed
President, Director
Dr. Larry Kaiser
Director
Mr. Stephen Buyer
Independent Director
Mr. Robert Ciaruffoli
Independent Director
Mr. James Datin
Independent Director
Mr. Gerald Goldberg
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-13 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 49 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.15

stock-summary
Return on Equity

-455.95%

stock-summary
Price to Book

9.47